Tectonic Therapeutic Inc Live Stock Price Today, Share Analysis and Chart

Name: Tectonic Therapeutic Inc.: Is Infosys Ltd. worth buying?
Item: Tectonic Therapeutic Inc.
Rating: 1.36191675
Author: Trendlyne DVM scores

about

Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD...

26.63 -0.37 (-1.37%)

32.63% Fall from 52W High

131.8K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.2 / 100

Technically Neutral

45.3 / 100

No estimates available

Tectonic Therapeutic Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tectonic Therapeutic Inc Live Stock Price Today, Share Analysis and Chart

Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD...

32.63% Fall from 52W High

SWOT Analysis

Tectonic Therapeutic Inc Live Price Chart

Tectonic Therapeutic Inc Live Price Chart